The results of the present study showed that CXCL5 enhanced cancer cell growth in vitro and in xenograft animal studies, a finding which agrees with other studies that have found CXCL5 to be associated with tumor progression in prostate cancer [6,7,40]. This evidence concerns the gene CXCL5 and prostate carcinoma.